Answers are grounded in this paper and cite their sources.
Policy analysis reveals the absence of parental health utility values after perinatal death, highlighting the need for robust cost-effectiveness evidence.
Policymakers use clinical and cost-effectiveness evidence to support decisions about health service commissioning. In England, the National Institute for Health and Care Excellence (NICE) recommend that in cost-effectiveness analyses "effectiveness" is measured as quality-adjusted life years (QALYs), derived from health utility values. The impact of perinatal death (stillbirth/neonatal death) on parents' health utility is currently unknown. This knowledge would improve the robustness of cost-effectiveness evidence for policymakers.
No takes yet. Share an insight, caveat, or question.
Camacho et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: